NCT06012708
- Conditions
- Advanced Solid Tumors
- Locations
-
- National Cancer Center Goyang-si, South Korea
Clinical trial condition
Advanced Solid Tumors
Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.
609 public trials
183 recruiting studies
Advanced Solid Tumors trial results
NCT04052971
- Conditions
- Advanced Solid Tumors
- Locations
-
- ST George Private Hospital Kogarah, New South Wales, Australia
- Sydney Southwest Private Hospital Liverpool, New South Wales, Australia
- Scientia Clinical Research Randwick, New South Wales, Australia
- Linear Clinical Research Perth, Western Australia, Australia
NCT04727554
- Conditions
- Advanced Solid Tumors
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Henry Ford Hospital, Henry Ford Health Systems Detroit, Michigan, United States
- University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
NCT00739453
- Conditions
- Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
- Locations
-
- University of Colorado Health Science Center Aurora, Colorado, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Hudson-Webber Cancer Research Center, Karmanos Cancer Institute Detroit, Michigan, United States
- University of Oxford Department of Medical Oncology Oxford, United Kingdom
Completed
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
NCT02057380
- Conditions
- Advanced Solid Tumors
- Locations
-
- Site US10004 La Jolla, California, United States
- Site US10006 Tampa, Florida, United States
- Site US10002 Baltimore, Maryland, United States
- Site US10008 Ann Arbor, Michigan, United States
Completed
Study of Continuous OSI-906 Dosing
NCT00514007
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
- Locations
-
- Vanderbilt Universtiy Medical Center Nashville, Tennessee, United States
- The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
Completed
Study of Intermittent OSI-906 Dosing
NCT00514306
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
- Drug Development Unit, Royal Marsden Hospital Sutton, Surrey, United Kingdom
NCT02561455
- Conditions
- Acute Myeloid Leukemia, Advanced Solid Tumors, Hematologic Diseases, +6 more
- Locations
-
- Site US10005 Phoenix, Arizona, United States
- Site US10003 Baltimore, Maryland, United States
- Site US10006 New York, United States
- Site US10007 New York, United States
Completed
Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors
NCT03945253
- Conditions
- Advanced Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Site JP81001 Chuo-ku, Tokyo, Japan
NCT01529684
- Conditions
- Advanced Solid Tumors, Neoplasms, Pharmacokinetics of 14C-OSI-906
- Locations
-
- Northwest Medical Specialties, PLLC Tacoma, Washington, United States
- Comprehensive Clinical Development NW, Inc. Tacoma, Washington, United States